Lightcalls.com
 

clan who regularly read books, do c...

clan who regularly read books, do crossword complicates or otherwise exercise their brains are significantly les likely to make known Alzheimer's disease, reports a reflection involving 801 elderly Catholic priests, nun and brothers.

Researchers at Rush-Presbyterian-St. Luke's Medical Center in Chicago studied participants aged 65 and older from 40 religious orders and societies. The subdues were tested to determine to what degree often they took part in various brain-stimulating activities: listening to the radio; reading newspapers, magazines or books; playing cards or board games; doing puzzles; and going to museums. They were followed for almost four years, annually taking a battery of experiments to evaluate memory, language and other indications of brain function.

Researchers reported in the February 13 2002 Journal of the American Medical Association that, forward average, those who said they not rarely take part in mentally stimulating activities were 47 percent les likely to unravel Alzheimer's disease than those who rarely do so



studious mood director David Bennett says researchers also place that the rate of decline of brain function was faster among those who rarely took part in activities that involve thinking. "It appears that keeping your mind active can, in fact, dull the rate at which you let slip mental ability," he says.

Whether brain stimulation obstructs disease or only reflects its absence has still to be proved, says Elisabeth Kos assistant director of the Alzheimer's Disease Center Program at the National Institute forward Aging, which funded the application of mind It's possible that people in the earliest stages of Alzheimer's disease may be les likely to take part in brain-exercising activities because they're already slightly impaired, she says. Or, it may be that stimulating the brain allows it to compensate for damage caused at disease or normal aging.

"The elderly idea that you're born with a certain number of brain solitary abode; squalids and you lose them, like hair, diverts out not to be the case," Kos says. There is evidence that mental calisthenics help create healthy might paths in the brain, which could replace those thrown away or impaired by disease.

COPYRIGHT 2002 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2002 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.